Insomnia
Conditions
Keywords
digital therapeutics
Brief summary
The purpose of the study was to determine safety and efficacy of WELT-IP in adult insomnia patients. WELT-IP is a cognitive behavioral therapy for insomnia (CBT-I) based digital therapeutics.
Detailed description
This was a randomized, double-blinded, sham-controlled trial. Overall, 68 subjects were randomized into the following groups: * WELT-IP group: WELT-IP (insomnia digital therapeutics) use * Control group: sham app use Subjects in both groups continued to receive their clinician-directed standard-of-care treatment for insomnia, if applicable, including pharmacotherapy. After screening of sleep diary, subjects were randomized and in WELT-IP group used WELT-IP and subjects in control group used a sham for a period of 6 weeks.
Interventions
DEVICEWELT-IP
WELT-IP (an investigational digital therapeutic) is an CBT-I based intervention designed to treat insomnia, conducted in 6 sessions. It is a comprehensive program delivering sleep restriction, stimulation control, muscle relaxation, cognitive treatment, and sleep hygiene education. Main features are sleep diary, sleep reports, daily lessons of CBT-I, muscle relaxation techniques, and cognitive intervention through chatbot.
DEVICESham
Sham was downloaded to the subject's phone and was subject was instructed to complete sleep diary and sleep educational contents as needed.
Sponsors
WELT corp
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Masking description
double-blinded
Intervention model description
This is a randomized, double-blinded design, with three points of measurement. The subjects will receive either the WELT-IP app or sham app.
Eligibility
Sex/Gender
ALL
Age
19 Years to 65 Years
Healthy volunteers
Yes
Inclusion criteria
* DSM-5 insomnia patient * SE (sleep efficiency) \<80% * completing screening sleep diary of 7 consecutive days * ISI of 8 or above * capable of using mobile device and application
Exclusion criteria
* currently on non-pharmacological treatment for insomnia (ex. CBT-I, light therapy, oriental therapy for insomnia) * sleep disorders diagnosis other than insomnia (ex. Obstructive sleep apnea, sleep behavior problem, restless leg syndrome) * progressive and active medical conditions * received continuous psychotherapy such as CBT, motivational enhancement therapy, psychotherapy, and psychoanalysis in the past 3 months * major psychiatric illness as assessed through MINI * suicide risk as assessed through C-SSRS * having occupational risk due to sleep restriction * shift workers
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline to week 7 (post-treatment) of Sleep efficiency(SE) | 7 weeks | Sleep efficiency is calculated as percentage of Total sleep time/Time in bed. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline to week 7 (post-treatment) of Number of awakening (NOA) | 7 weeks | Number of awakening is evaluated as the number of times a person wakes up after falling asleep. |
| Change from baseline to week 7 (post-treatment) of Generalized anxiety disorder-7 item scale (GAD-7) | 7 weeks | Generalized anxiety disorder-7 item scale has seven questions. Total score ranges from 0 to 21, where higher scores indicate more acute symptoms of anxiety. |
| Percentage of subjects achieving SE ≥ 85% | 7 weeks | — |
| Compliance (completion rate of lessons, for WELT-IP group only) | 7 weeks | Compliance is evaluated as completion rate of lessons. |
| Change from baseline to week 7 (post-treatment) of Sleep onset latency (SOL) | 7 weeks | Sleep onset latency is evaluated as the time it takes a person to fall asleep after going to bed. |
| Change from baseline to week 7 (post-treatment) of Sleep quality (SQ) | 7 weeks | Sleep quality ranges from 1 to 5, where higher score indicates better quality of sleep. |
| Change from baseline to week 7 (post-treatment) of Wake after sleep onset (WASO) | 7 weeks | Wake after sleep onset is calculated as the total number of minutes that a person is awake after initially falling asleep. |
| Change from baseline to week 7 (post-treatment) of Total sleep time (TST) | 7 weeks | Total sleep time is calculated as the total number of minutes that a person actually sleep. |
| Change from baseline to week 7 (post-treatment) of Insomnia severity index (ISI) | 7 weeks | Insomnia severity index has seven questions. Total score ranges from 0 to 28, where higher scores indicate more acute symptoms of insomnia. |
| Change from baseline to week 7 (post-treatment) of Dysfunctional beliefs and attitudes about sleep-16 (DBAS-16) | 7 weeks | Dysfunctional beliefs and attitudes about sleep-16 has sixteen questions. Responses can range from 0 to 10, where higher scores indicate more irrational beliefs and attitudes toward sleep. |
| Change from baseline to week 7 (post-treatment) of Patient health questionnaire-9 (PHQ-9) | 7 weeks | Patient health questionnaire-9 has nine questions. Total score ranges from 0 to 27, where higher scores indicate more acute symptoms of depression. |
Other
| Measure | Time frame | Description |
|---|---|---|
| Activity data from mobile device | 7 weeks | Activity data is evaluated as change of number of steps from baseline to week 7. |
| App Satisfaction Survey | 7 weeks | — |
| Sleep Environment Survey | 7 weeks | — |
Countries
South Korea
Outcome results
None listed